BridgeBio Pharma racks up $299.2 mln


BridgeBio Pharma, a clinical-stage biopharmaceutical company focused on genetic diseases, has raised $299.2 million in funding. KKR and Viking Global Investors led the round with participation from other investors that included Perceptive Advisors, AIG, Aisling Capital, Cormorant Capital, Hercules Capital and Sequoia Capital.

Source: Press Release